Capital Raising
Funding rounds, IPOs and capital events — capital raised becomes leadership hired.
Last updated
1,618
signals · last 90 days
1,435
trailing 4 weeks
18% ↑
share of signal mix
122.7
Talent Market Index · Hot →
On the wire — capital raising
Our intelligence detected 1,435 capital raising signals corpus-wide in the trailing four weeks. Below is the verified, sourced selection — every entry carries a checked source link and persists as its own page.
Ramp
AmericasRamp raised $750M in Series F funding at a $44B valuation, part of a digital banking funding surge that nearly doubled quarter-over-quarter to $2.6B
Leadership read: Ramp's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Americas.
curated · 2026-08-06 · context →
Oviva
EMEAOviva received significant healthtech funding in H1 2026 alongside Isomorphic Labs as part of the UK's healthcare investment activity.
Leadership read: Fresh capital is a hiring signal before it is anything else. For Oviva, a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where Oviva hires first across EMEA; that is where the capital is really pointed.
curated · 2026-08-06 · context →
Nayax
AmericasIsraeli payments and loyalty platform Nayax filed an application to charter a bank in the US, signaling intent to expand financial services capabilities and access regulated banking infrastructure.
Leadership read: Nayax's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Americas.
curated · 2026-08-06 · context →
Humanoid
AmericasHumanoid raised $152M at $1.35B valuation following partnerships with Bosch, Siemens, and Schaeffler for industrial automation and manufacturing
Leadership read: Humanoid's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Americas.
curated · 2026-08-06 · context →
Hyperplane
Americas · ConsultingAI-native wealth advisory platform founded by ex-Nubank CTO raised $85 million in funding.
Leadership read: Fresh capital is a hiring signal before it is anything else. For Hyperplane, a raise in Consulting funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where Hyperplane hires first across Americas; that is where the capital is really pointed.
curated · 2026-08-06 · context →
Airwallex
Americas · Financial ServicesAirwallex raised $320M in Series H funding at a $11B valuation, contributing to record digital banking funding in Q2 2026
Leadership read: Airwallex's raise resets the leadership agenda more than the balance sheet. Capital into Financial Services buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Americas.
curated · 2026-08-06 · context →
ICEYE
EMEAICEYE, Europe's sovereign intelligence from space leader, closed a €1 billion funding round co-led by EQT's Scaleup Europe Fund. Round included €450 million in primary proceeds.
Leadership read: ICEYE's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across EMEA.
curated · 2026-08-05 · context →
Twist Bioscience
Americas · Biotech & PharmaTwist Bioscience priced a $300 million stock offering at $96 per share, indicating successful capital raise in public markets.
Leadership read: Twist Bioscience's raise resets the leadership agenda more than the balance sheet. Capital into Biotech & Pharma buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Americas.
curated · 2026-08-05 · context →
Moss
EMEAFintech startup Moss achieved unicorn status with €30m Series C funding round, becoming Europe's newest unicorn.
Leadership read: Moss's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across EMEA.
curated · 2026-08-05 · context →
Thomas & Company
AmericasThomas & Company, a workforce compliance solutions platform, received a strategic investment from BV Investment Partners (a middle-market PE firm) to fund accelerated growth and expansion across the HR ecosystem.
Leadership read: Thomas & Company's raise resets the leadership agenda more than the balance sheet. Capital into the sector buys room to build senior operating and commercial bench strength ahead of scale. The near-term tilt favours operators who have scaled before; the appointments that follow say more than the announcement did across Americas.
curated · 2026-08-04 · context →
Vita Coco Company
AmericasVita Coco filed a US$34.77 million common stock shelf registration in late July 2026, signaling preparation for potential equity capital raise. Company also completed a US$44.07 million share repurchase in the same period.
Leadership read: Fresh capital is a hiring signal before it is anything else. For Vita Coco Company, a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where Vita Coco Company hires first across Americas; that is where the capital is really pointed.
curated · 2026-08-04 · context →
Scalare Partners
OceaniaASX-listed Scalare Partners plans a $5 million capital raise following its acquisition of Fishburners
Leadership read: Scalare Partners raising is a leading indicator for everyone it is about to fund. Capital at the fund level converts into operator demand across a portfolio, not into appointments at the manager. The Oceania question is which stage and sector the fund leans into, because that is the shape of the hiring that follows next year.
curated · 2026-08-04 · context →
- Ramp · 2026-08-06
- Oviva · 2026-08-06
- Nayax · 2026-08-06
- Humanoid · 2026-08-06
- Hyperplane · 2026-08-06
- Airwallex · 2026-08-06
- ICEYE · 2026-08-05
- Twist Bioscience · 2026-08-05
- Moss · 2026-08-05
- Thomas & Company · 2026-08-04
- Vita Coco Company · 2026-08-04
- Scalare Partners · 2026-08-04
- Blue Owl Capital Inc. · 2026-08-04
- Cerberus Capital Management · 2026-08-04
- Convex · 2026-08-04
- Factory · 2026-08-04
- 10x Banking · 2026-08-04
- Moment · 2026-08-04
- Guardant Health · 2026-08-04
- Gryphon Investors · 2026-08-04
- Zepto Ltd. · 2026-08-03
- Quanta Services, Inc. · 2026-08-03
- Maximum · 2026-08-03
- NEXTDC · 2026-08-02
How this connects
Related companies
Recent developments
- Zoono Group — Capital Raising · Oceania · 2026-10-19
- 주빅 (JUVIC) — Capital Raising · Asia · 2026-10-19
- Blue Whale — Capital Raising · Asia · 2026-10-19
- The Pant Project — Capital Raising · Asia · 2026-10-19
- Hunger Pangs Pvt Ltd — Capital Raising · Asia · 2026-10-19
- Salmon Group — Capital Raising · Asia · 2026-10-19
Proof — case studies
- Executive search for HR-tech · Culture Amp
In their words
“the financial complexities of building and operating new clouds and selling to customers.”
“x402 answers how an agent pays, x401 answers who it is. Those are the first two questions any agentic transaction has to clear, and now each has an open standard.”
“a merger would create a leader in microbiome and infectious disease diagnostics, with broader revenue and customer bases and a materially stronger balance sheet to meet the significant global opportunity facing the merged group.”
- Data period
- 20 Mar 2026 – 19 Oct 2026 · 2,698 signals in this type
- Methodology
- How this is computed
- Publisher
- MitchelLake
Last updated
